Vulnerabilities

Vulnerability · CVE-2026-27505

SVXportal version 2.5 and prior contain a stored cross-site scripting vulnerability in the user registration workflow (index.php submitting to admin/user_action.php).

Published Feb 20, 2026 · catalog updated Jul 14, 2026 · SVXportal version 2.5 and

Check if you run it

No confirmed exploitation is on record for CVE-2026-27505. EPSS is 0.33%. Act only if a listed version of SVXportal version 2.5 and is installed.

Gaps on this record

  • The stored product name is a package slug. The name on this page is taken from the title (SVXportal version 2.5 and).
  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Medium5.1
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.33%
Remediation
Advisory link
Affected products
cpe radioinorr/svxportal

SVXportal version 2.5 and prior contain a stored cross-site scripting vulnerability in the user registration workflow (index.php submitting to admin/user_action.php). User-supplied fields such as Firstname, lastname, and email are stored in the backend database without adequate output encoding and are later rendered in the administrator interface (admin/users.php), allowing an unauthenticated remote attacker to inject arbitrary JavaScript that executes in an administrator's browser upon viewing the affected page.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • cpe radioinorr/svxportalversion unspecified

How to fix CVE-2026-27505

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2026-27505. EPSS is 0.33%. Act only if a listed version of SVXportal version 2.5 and is installed.

Which versions are affected?

Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-79: Cross-site Scripting (XSS). EPSS 0.33%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

Timeline

Detection, updates, and resolution for this record.

  1. Feb 20, 2026 · NIST NVD

    Detected

    SVXportal version 2.5 and prior contain a stored cross-site scripting vulnerability in the user registration workflow (index.php submitting to admin/user_action.php). User-supplied fields such as Firstname, lastname, and email are stored in the backend database without adequate output encoding and are later rendered in the administrator interface (admin/users.php), allowing an unauthenticated remo

  2. Jul 14, 2026 · NIST NVD

    Updated

    SVXportal version 2.5 and prior contain a stored cross-site scripting vulnerability in the user registration workflow (index.php submitting to admin/user_action.php). User-supplied fields such as Firstname, lastname, and email are stored in the backend database without adequate output encoding and are later rendered in the administrator interface (admin/users.php), allowing an unauthenticated remo

Sources

  • CVE.orgVulnerability recordCVE-2026-27505

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2026-27505

    30-day exploitation probability 0.3%

    first.org
  • NIST NVDVulnerability recordCVE-2026-27505

    SVXportal version 2.5 and prior contain a stored cross-site scripting vulnerability in the user registration workflow (index.php submitting to admin/user_action.php). User-supplied fields such as Firstname, lastname, and email are stored in the backend database without adequate o

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.